Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment
- PMID: 26315844
- DOI: 10.1038/ijo.2015.175
Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment
Abstract
Background/aims: Lifestyle intervention is the only established therapy for non-alcoholic fatty liver disease (NAFLD). The optimal treatment schedule and predictors of response of this treatment have not been established in children. We aimed to evaluate the 2-year efficacy of an inpatient versus ambulatory intensive lifestyle intervention for treating NAFLD in children with severe obesity.
Methods: A cohort study of 51 severely obese non-diabetic children (mean age 14.7 (±2.4) years; BMI-z-score 3.5 (±0.5)) with liver steatosis were non-randomly allocated to inpatient treatment (2 or 6 months), ambulatory treatment or usual care. Proton Magnetic Resonance Spectroscopy determined liver steatosis and serum alanine aminotransferase (ALT) at 6 months were the primary outcome measures. Baseline variables were evaluated as predictors of treatment response.
Results: Liver steatosis had disappeared in 43, 29 and 22% and serum ALT normalized in 41, 33 and 6% at the end of 6 months in the inpatient, ambulatory or usual care treatment groups, respectively. Only the proportions of ALT normalization in inpatient and ambulatory treatment compared with usual care were significantly higher. Treatment effects of inpatient and ambulatory treatment were sustained at 1.5 years follow-up. No baseline characteristic, including PNPLA3 polymorphism or leptin, was consistently predictive for treatment response.
Conclusions: A 6-month intensive inpatient and ambulatory lifestyle treatment in children with severe obesity reverses NAFLD in a minority of patients. This study suggests that inpatient compared with ambulatory intensive treatment does not importantly increase treatment success. Further efforts to optimize and individualize lifestyle interventions and additional treatments options are needed particular for children with severe obesity resistant to conventional lifestyle interventions.
Similar articles
-
Inpatient treatment of children and adolescents with severe obesity in the Netherlands: a randomized clinical trial.JAMA Pediatr. 2014 Sep;168(9):807-14. doi: 10.1001/jamapediatrics.2014.521. JAMA Pediatr. 2014. PMID: 25022831 Clinical Trial.
-
Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement.Arch Dis Child. 2011 Jul;96(7):669-74. doi: 10.1136/adc.2010.199760. Epub 2011 Apr 25. Arch Dis Child. 2011. PMID: 21518734
-
The macrophage activation marker sCD163 is associated with changes in NAFLD and metabolic profile during lifestyle intervention in obese children.Pediatr Obes. 2015 Jun;10(3):226-33. doi: 10.1111/ijpo.252. Epub 2014 Jul 30. Pediatr Obes. 2015. PMID: 25073966
-
Severe childhood obesity: an under-recognised and growing health problem.Postgrad Med J. 2015 Nov;91(1081):639-45. doi: 10.1136/postgradmedj-2014-133033. Epub 2015 Sep 3. Postgrad Med J. 2015. PMID: 26338983 Review.
-
Non-Alcoholic Fatty Liver Disease in Children and Adolescents: Lifestyle Change - a Systematic Review and Meta-Analysis.Ann Hepatol. 2018 May-June;17(3):345-354. doi: 10.5604/01.3001.0011.7380. Epub 2018 Apr 9. Ann Hepatol. 2018. PMID: 29735796
Cited by
-
Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.Dig Dis Sci. 2016 May;61(5):1375-86. doi: 10.1007/s10620-016-4126-1. Epub 2016 Apr 4. Dig Dis Sci. 2016. PMID: 27041377 Free PMC article. Review.
-
Beverage consumption and paediatric NAFLD.Eat Weight Disord. 2016 Dec;21(4):581-588. doi: 10.1007/s40519-016-0315-3. Epub 2016 Aug 26. Eat Weight Disord. 2016. PMID: 27565159 Review.
-
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?Endocrine. 2024 Sep;85(3):988-1006. doi: 10.1007/s12020-024-03783-7. Epub 2024 Mar 22. Endocrine. 2024. PMID: 38519764 Free PMC article. Review.
-
Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease.Gastroenterol Hepatol (N Y). 2018 Jul;14(7):407-414. Gastroenterol Hepatol (N Y). 2018. PMID: 30166956 Free PMC article.
-
Effects of an exercise program on hepatic metabolism, hepatic fat, and cardiovascular health in overweight/obese adolescents from Bogotá, Colombia (the HEPAFIT study): study protocol for a randomized controlled trial.Trials. 2018 Jun 25;19(1):330. doi: 10.1186/s13063-018-2721-5. Trials. 2018. PMID: 29941024 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical